Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ETRM

Enteromedics (ETRM)

Enteromedics
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ETRM
DateTimeSourceHeadlineSymbolCompany
24/10/201707:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
23/10/201723:30PR Newswire (US)EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS)NASDAQ:ETRMEnteromedics
18/10/201707:15Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ETRMEnteromedics
16/10/201723:00PR Newswire (US)EnteroMedics Announces Presentations at ObesityWeek 2017NASDAQ:ETRMEnteromedics
13/10/201709:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETRMEnteromedics
13/10/201709:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETRMEnteromedics
13/10/201709:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETRMEnteromedics
13/10/201707:52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ETRMEnteromedics
13/10/201707:46PR Newswire (US)EnteroMedics Announces New Employee Inducement Option GrantsNASDAQ:ETRMEnteromedics
07/10/201700:04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ETRMEnteromedics
03/10/201723:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
03/10/201723:47Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ETRMEnteromedics
03/10/201723:30PR Newswire (US)EnteroMedics Announces Acquisition Of ReShape MedicalNASDAQ:ETRMEnteromedics
12/09/201722:30PR Newswire (US)EnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare ConferenceNASDAQ:ETRMEnteromedics
06/09/201706:15PR Newswire (US)EnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc TherapyNASDAQ:ETRMEnteromedics
29/08/201706:05PR Newswire (US)Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-EffectiveNASDAQ:ETRMEnteromedics
25/08/201707:02Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:ETRMEnteromedics
21/08/201723:00PR Newswire (US)EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in MarylandNASDAQ:ETRMEnteromedics
17/08/201707:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
16/08/201723:00PR Newswire (US)EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual ConferenceNASDAQ:ETRMEnteromedics
16/08/201706:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETRMEnteromedics
12/08/201706:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETRMEnteromedics
11/08/201722:20PR Newswire (US)EnteroMedics Announces Pricing of $20 Million Underwritten Public OfferingNASDAQ:ETRMEnteromedics
11/08/201722:12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
11/08/201706:34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETRMEnteromedics
11/08/201706:34PR Newswire (US)EnteroMedics Announces Proposed Underwritten Public OfferingNASDAQ:ETRMEnteromedics
09/08/201706:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ETRMEnteromedics
08/08/201722:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETRMEnteromedics
08/08/201721:00PR Newswire (US)EnteroMedics Announces Second Quarter 2017 Financial ResultsNASDAQ:ETRMEnteromedics
02/08/201721:00PR Newswire (US)EnteroMedics To Discuss Business Strategy And Financial Results For The Second Quarter Of 2017NASDAQ:ETRMEnteromedics
 Showing the most relevant articles for your search:NASDAQ:ETRM